Skip to Main Content

Dr. Peter Stock is a transplant surgeon who specializes in kidney, liver and pancreas transplants. He is co-director of the Pancreatic Islet Cell Transplantation Program.

In his research, Stock studies body mechanisms that lead to transplant rejection when the donor and recipient are not genetically identical. He also studies chimerism (a therapy to prevent transplant rejection that uses the donor's bone marrow cells) and pancreatic islet cell transplantation (a procedure that can allow people with type 1 diabetes to discontinue insulin therapy).

Stock received his medical training at the University of Minnesota, completing a surgical residency before coming to UCSF for a transplant fellowship. He joined the UCSF faculty in 1992.

Stock is an active teacher and supervises surgical residents and fellows. He is a member of numerous professional and honorary societies.

  • Education

    University of Illinois School of Medicine, 1982

  • Residencies

    University of Minnesota Medical Center, General Surgery, 1990

  • Fellowships

    UCSF Medical Center, Transplant Surgery, 1992

  • Board Certifications

    Surgery, American Board of Surgery

  • Academic Title

    Professor

Where I see patients (3)

    My reviews

    5.0

    Overall Experience
    62 Ratings
    About our process
    Feb 16, 2023
    My transplant team made me feel very comfortable with my decision
    Oct 12, 2022
    This was the first time seeing this doctor but really enjoyed him. He stayed on topic and asked questions and was very supportive and positive
    Oct 08, 2022
    Staff was very professional and caring
    Aug 04, 2022
    Took sufficient time to explain and answer questions. I did not feel rushed.
    Apr 06, 2022
    Excellent visit
    Jan 26, 2022
    Dr. Stock was excellent knowledgeable professional and courteous. The best I could ever want.
    Jan 26, 2022
    Very good
    Jan 21, 2022
    I feel like my sis and I can trust the care will be receiving
    Jun 14, 2021
    excellent
    May 25, 2021
    great
    May 25, 2021
    everything was all properly discussed

    Selected research

    Share